Effinity Tech is the developer of an innovative process system engineering technology called Directional Control Technology (DCT) that is transforming process development and optimization in the biosciences and chemical industries. Unlike traditional methodologies, which require a large number of experiments and a significant amount of guesswork, DCT’s systematic approach enables our clients to meet their objectives rapidly within 10 experiments, and bring their products to market faster while achieving the highest levels of quality in a cost effective manner.
DCT is based on modern system theories and principles rather than statistics and/or individual experience. It can optimize system configurations and parameter values simultaneously.
100+ projects in areas as varied as chemical synthesis, fermentation, cell culture development, peptide synthesis and vaccine production have proven the effectiveness and power of DCT.
As an example, with only 6 experiments, DCT helped a leading CMO to develop a cell culture platform with 67 parameters, increasing the yield of target protein by 78% within 3 months.
News & Events
Effinity Tech to Attend BioProcess International Conference & Exhibition 2014
Effinity Tech will be attending the BioProcess International Conference & Exhibition 2014 October 20-23 at Hynes Convention Center in Boston, MA. Helena Fan, our VP of Business Development, will be attending and meeting with clients about Effinity Tech’s breakthrough process optimization technology known as Directional Control Technology (DCT).Read more»
Effinity Tech Becomes SIMB Bronze Corporate Member
Effinity Tech is now a Bronze Corporate Member for the Society of Industrial Microbiology and Technology (SIMB). We are happy to lend our support to this professional association of microbiology experts and look forward to participating in SIMB events in the future.